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Radiotherapymay compromise the integration of implant and cause implant loss. Implant surfacemodifications have the possibility
of promoting cell attachment, cell growth, and bone formation which ultimately enhance the osseointegration process.The present
study aimed to investigate the effects of calcium phosphate nanocrystals on implant osseointegration in irradiated bone. Sixteen
rabbits were randomly assigned into control and nano-CaP groups, receiving implants with dual acid-etched surface or dual acid-
etched surface discretely deposited of nanoscale calcium-phosphate crystals, respectively. The left leg of all the rabbits received
15Gy radiation, followed by implants placement one week after. Four animals in each group were sacrificed after 4 and 12 weeks,
respectively. Implant stability quotient (ISQ), ratio of bone volume to total volume (BV/TV), bone growth rate, and bone-to-implant
contact (BIC) were evaluated. The nano-CaP group showed significantly higher ISQ (week 12, 𝑃 = 0.031) and bone growth rate
(week 6, 𝑃 = 0.021; week 9, 𝑃 = 0.001) than that in control group. No significant differences in BV/TV and BIC were found
between two groups. Titanium implant surface modified with CaP nanocrystals provides a potential alternative to improve bone
healing around implant in irradiated bone.
1. Introduction
The success of implant osseointegration depends on the
quality and quantity of the surrounding bone [1]. Radio-
therapy has been considered as one of the predominant
factors causing implant loss [2, 3]. It alters the circulation
and metabolism of bone. Irradiation injures the small blood
vessels leading to persistent hypoxia and reduces the quantity
and activity of osteoblasts [4]. A number of studies showed
that the failure rate of implants placed in irradiated bone was
higher than those in nonirradiated bone [5–7]. This finding
was confirmed in our previous study on a rabbit model [8].
The radiation at 15Gy demonstrated a significantly adverse
effect on implant stability and BV/TV.
Implant surface modifications may promote cell attach-
ment, cell growth, and bone formation which ultimately
enhances the osseointegration process. The surface modi-
fication includes physical method, chemical method, or a
combination of both [9].TheCaP coated implant has demon-
strated enhanced osteoconductive properties in normal bone
[10, 11]. However, to our best knowledge no studies have
investigated the osseointegration of CaP coated implant in
irradiated bone.
The present study investigated the stability and osseoin-
tegration of CaP coated implant using our radiation compro-
mised rabbit model [8].
2. Materials and Methods
2.1. Animal Care and Grouping. The animal experiment was
approved by the Committee on the Use of Live Animals
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Sixteen adult, male New Zealand white rabbits (8-9 months
old) were randomly assigned into control and nano-CaP
groups, eight in each. Rabbits in control group received
implants with dual acid-etched surface (Osseotite, Biomet 3i
Implant Innovations Inc., Palm Beach Gardens, FL, USA),
while rabbits in nano-CaP group received implants with
dual acid-etched surface discretely deposited of nanoscale
calcium-phosphate crystals (Nanotite, Biomet 3i Implant
Innovations Inc., Palm Beach Gardens, FL, USA). The time-
line of treatment was presented in Table 1.
2.2. Radiation. Radiation on rabbits was performed by radio-
therapists in Department of Clinical Oncology, Queen Mary
Hospital, The University of Hong Kong, using the protocol
reported in our previous study [8]. The tibial and femoral
metaphysis region of left hind leg was subjected to a single
dose of 15Gy irradiation, whereas the other parts of the
animals were protected. Electron beams of 9MeV from a
Varian Clinac 2100CD were delivered with a 15 × 15 cm2
applicator at a source to surface distance of 60 cm.
2.3. Implant Surgery. Implant surgery was performed one
week after radiation. Under general anesthesia, parallel
walled titanium implants with screw threads (3.25mm ×
8mm)were placed in tibial and femoralmetaphysic following
the standardized protocol reported in our previous study
[8]. Each animal received two implants on irradiated leg,
one implant on tibia and one on femur. Totally 16 control
implants and 16 nano-CaP implants were placed by the same
surgeon. After surgery, appropriate antibiotics and analgesics
were administered. Four rabbits in each groupwere sacrificed
4 weeks and 8 weeks after implant surgery, respectively.
The implants together with 3–5mm surrounding bone were
harvested en bloc and fixed in 10% neutral formaldehyde.
The timetable of radiation, implant surgery, fluorochrome
labeling injection, and sacrifice is shown in Table 1.
2.4. Implant Stability Measurement. Resonance frequency
analysis (RFA) device (Osstell; Integration Diagnostics,
Savedalen, Sweden) was used to measure implant stability
quotient (ISQ). Primary stability (ISQps) represented the
ISQ value that was immediately measured after implant
placement while secondary stability (ISQss) represented the
ISQ value that was measured before sample retrieval.
2.5. Microcomputed Tomography (Micro-CT). After being
fixed in the formaldehyde for 2 days, the samples were
wrapped in Parafilm (SERVA Electrophoresis GmbH, Hei-
delberg, Germany) and subjected to micro-CT assessment
(Skyscan-1076 X-ray microtomograph, Skyscans, Kontich,
Belgium). The samples were scanned at energy of 101 kV
and intensity of 96mA with a resolution of 9mm pixel
using an aluminum filter (1mm). A threshold was selected
to differentiate the titanium implant, bone, and background
using the protocol described in our previous study [8]. The
bone surrounding the implant at a distance of 180 𝜇m from
the implant surface was analyzed, and the bone volume/total
volume (BV/TV) was measured.
2.6. Fluorochrome Labeling. Three kinds of fluorochrome
labeling, including alizarin red (25mg/kg), calcin green
(30mg/kg), and oxytetracycline (50mg/kg), were injected in
chronological order (Table 1). For the rabbits sacrificed at
week 4, the fluorochrome labeling was injected at week 1,
week 2, and week 3, respectively. For the rabbits sacrificed at
week 12, the fluorochrome labeling was injected at week 3,
week 6, and week 9, respectively. After sacrifice, samples were
embeddedwithmethylmethacrylate (MMA,Technovit 7500,
Kulzer, Hamburg, Germany). The embedded sample was
sawed along the long axis of implant into a section with 200–
500𝜇m thick, which was then polished to about 100 𝜇m.The
prepared slides were examined under fluorescentmicroscopy
(FluoView FV 1000; Olympus, Tokyo, Japan). The bone
growth rate was calculated as the average distance between
every two fluorochrome-labeled lines over the known time
interval of two corresponding injections.
2.7. Histomorphometric Analysis. After fluorescent micros-
copy examination, the slides were stained with toluidine
blue for 30min. Histomorphometrical analysis was per-
formed using a camera-equipped light microscope system
(Eclipse LV100POL,Nikon, Japan) and a computerized image
analyzer (NIS-Elements AR 3.00). Bone-to-implant contact
(BIC) was calculated as the length of the bone in direct
contact with the implant over the implant length.
2.8. Statistical Analysis. All measurements were conducted
by one trained, blinded, and calibrated examiner (single
measures intraclass correlation coefficient >0.60). Repeated
measures ANOVA (SPSS Inc., Chicago, IL, USA) were used
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Table 2: Values of implant primary stability (ISQps), secondary stability (ISQss), ratio of bone volume to total volume (BV/TV), and
percentage of bone to implant contact (BIC).
ISQps ISQss BV/TV (%) BIC (%)
Control group (4w) 65.25 ± 8.01 71.25 ± 4.98 55.57 ± 8.08 61.8 ± 8.1
Nano-CaP group (4w) 63.75 ± 6.23 69.63 ± 5.15 53.31 ± 7.35 57.9 ± 8.8
Control group (12w) 63.13 ± 5.54 74.25 ± 6.14 64.16 ± 8.20 64.3 ± 9.7
Nano-CaP group (12w) 64.38 ± 7.37 78.25 ± 8.63 65.59 ± 8.54 70.2 ± 8.6
(a) (b) (c) (d)
Figure 1: Micro-CT 3D images. (a) Control implant at week 4; (b) nano-CaP implant at week 4; (c) control implant at week 12; (d) nano-CaP
implant at week 12. Green color represents implant surface and grey color represents bone.
to compare ISQ, BV/TV, bone growth rate, and BIC. Time
and implant surface were defined as the factors. The level of
significant difference was set at 𝑃 ≤ 0.05.
3. Results
3.1. Clinical Assessment. All sixteen rabbits completed the
experiment uneventfully. No postoperative complications
were observed till sacrifice. The implants remained sub-
merged and soft tissues were clinically healthy.
3.2. Implant Stability. No significant difference in primary
stability (ISQps) was found among all groups at baseline
(Table 2). The secondary stability (ISQss) was significantly
higher than ISQps in all the groups (𝑃 < 0.001). Significant
difference of the secondary ISQ (ISQss) between control and
nano-CaP groups was not detected at week 4 (𝑃 = 0.602),
but at week 12 (𝑃 = 0.031). When compared groups from the
two time points, the nano-CaP implant groups showed that
ISQss at week 12 was significantly higher than that at week 4
(𝑃 = 0.004).
3.3.Micro-CT. Therepresentative images ofmicro-CT three-
dimensional (3D)models of bone formation around implants
are shown in Figure 1.The BV/TV at week 12 was significantly
higher than that at week 4 in both groups (control:𝑃 = 0.042;
nano-CaP: 𝑃 = 0.005) (Table 2). No significant difference of
BV/TV was found between control and nano-CaP groups at
week 4 (𝑃 = 0.579) and week 12 (𝑃 = 0.724).
Table 3: The mean and SD of bone growth rate (𝜇m/day).
Group Week 1 Week 2 Week 3
Control group (4w) 1.21 ± 0.54 1.81 ± 0.47 1.58 ± 0.39
Nano-CaP group A (4w) 1.24 ± 0.30 1.37 ± 0.54 1.20 ± 0.51
Week 3 Week 6 Week 9
Control group (12 w) 1.07 ± 0.27 1.22 ± 0.42 1.19 ± 0.41
Nano-CaP group (12w) 1.33 ± 0.53 2.74 ± 1.60 2.85 ± 0.97
3.4. Fluorescence Observation. Fluorescence microscopy
images are shown in Figure 2 and the measurements of
bone growth rate are shown in Table 2. Comparing bone
growth rates between different time points, the control
groups showed that the growth rates at weeks 2 and 3
were marginally significantly higher than that at week 1
(𝑃 = 0.050), but no significant differences were found at later
stages among weeks 3, 6, and 9 (𝑃 = 0.700). The nano-CaP
groups showed a stable bone growth rate in the first 3 weeks
(𝑃 = 0.742), but the growth rates at weeks 6 and 9 were
significantly higher than the rate at week 3 (𝑃 = 0.022).
When compared the nano-CaP and control groups, no
significant differences of bone growth rates were found in the
first three weeks. At later stages, the bone growth rate of the
nano-CaP group was significantly higher than that of control
group at week 6 (𝑃 = 0.021) andweek 9 (𝑃 = 0.001) (Table 3).
3.5. Histomorphological Analysis. Histological images
showed that implants of control and nano-CaP groups were
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Figure 2: Fluorochrome labeling images under fluorescence microscopy. (a) and (e) control implant at week 4; (b) and (f) nano-CaP implant
at week 4; (c) and (g) control implant at week 12; (d) and (h) nano-CaP implant at week 12. Red color is labeled by alizarin red at week 1 or
week 3, green color is labeled by calcin green at week 2 or week 6, and yellow color is labeled by oxytetracycline at week 3 or week 9.
well integrated with the surrounding bone. No inflammation
was observed. The new bone was directly in contact with the
implant surface (Figure 3). No change in BIC was found in
the control group (𝑃 = 0.158), while there was a significant
increase in BIC in the nano-CaP group from week 4 to
week 12 (𝑃 = 0.009) (Table 2). No significant differences
were found between control and nano-CaP groups at week 4
(𝑃 = 0.390) and at week 12 (𝑃 = 0.184) (Table 2).
4. Discussion
Rabbit has been used in many studies to investigate implant
osseointegration in irradiated bone [7, 8, 12]. Our previous
study using the same animal model demonstrated a dose-
dependent effect of radiation on bone healing around dental
implants [8]. The implant stability and bone volume was
significantly compromised by a single dose of 15Gy radiation
[8].
Different surface modifications for titanium implants
have been advocated to shorten the time of osseointegration
[13, 14]. Calcium phosphate (CaP) is reported to promote cell
attachment, proliferation, differentiation, and the production
of extracellular matrix (ECM) in vitro [15, 16]. The favorable
property of CaP coating might be due to the similarity of
chemical composition between CaP coating and natural bone
[17]. CaP coatings on titanium surface simulate the organic
and inorganic components of natural bone tissue, which
guides bone formation along the implant-bone interface [18].
CaP dissolved and delivered into the peri-implant region
also raises the saturation level of body fluid and results in
deposition of biological apatite on the surface of implants
[19]. Nano-CaP implants, on the other hand, might have the
potential of enhancing the “secondary” stability. This might
be clinically useful not only for patientswhohad radiotherapy
but also in other compromised bone conditions such as
osteoporosis or inadequate bone height.
A number of studies have investigated discrete crystalline
deposition (DCD) of calcium phosphate on implant surface;
however, its effect on osseointegration was controversial.
Most of the studies showed that nano-CaP coating of titanium
surface could promote bone formation on implant surface,
raise the torque required to remove implants, and increase
BIC [20–23]. However, some studies found that the nano-
CaP coating did not enhance early bone tissue integration
in animal [24, 25] and clinical studies [26]. The discrepancy
might be due to the different experimental model and time
points for assessment. While most of the studies which
assessed the osseointegration at or before week 4 did not find
significant difference between nano-CaP group and control
group, the long-term studies with the observation done
after several months detected a difference. The present study
showed no difference in secondary stability value at week 4,
while the significantly higher ISQss value was detected in
nano-CaP group at week 12. Our study also found that the
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Figure 3: Histological images under light microscopy. (a) and (e) control implant at week 4; (b) and (f) nano-CaP implant at week 4; (c) and
(g) control implant at week 12; (d) and (h) nano-CaP implant at week 12.
bone growth rate was significantly higher in nano-CaP group
at week 6 and week 9. The identical results of increased ISQ
and bone growth rate at the late stage of the present study
suggested that nano-CaP surface modification may improve
osseointegration in longer term rather than in early stage after
implant placement.
The present study did not find any differences in BIC
and BV/TV between nano-CaP and control groups. This
might be due to the limitation of sample size and observation
time. A further study using a larger sample size with longer
observation period is necessary.
5. Conclusions
Titanium implant surface modified with CaP nanocrystals
may have potential to improve implant osseointegration in
irradiation compromised bone. Further study with larger
sample size and longer observation period is necessary.
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